A Comprehensive Review on the Bioactive Potential of Hopea parviflora in Modern Medicine

Hopea parviflora Bedd, belonging to the Dipterocarpaceae family, is a relatively underexplored medicinal species indigenous to the Indian subcontinent. Traditionally employed in folk medicine, this plant has recently garnered attention for its wide range of pharmacological activities. The present review consolidates and critically evaluates the available scientific literature on the phytochemical composition and therapeutic potential of H. parviflora, with a focus on its antioxidant, anti-inflammatory, antimicrobial, antidiabetic, and wound-healing properties. Rich in biologically active compounds including flavonoids, polyphenols, terpenoids, and tannins, the plant demonstrates multiple pharmacodynamic actions. Experimental studies conducted both in vitro and in vivo suggest that H. parviflora holds promise in the management of oxidative stress and metabolic disorders. However, current research is still in its early stages, and comprehensive preclinical and clinical studies are warranted to substantiate its medicinal value. This review seeks to establish a solid platform for future investigations and to support the advancement of H. parviflora as a viable candidate in phytopharmaceutical development. While initial experimental findings are encouraging, there remains a critical need for detailed clinical studies and mechanistic research to confirm the therapeutic efficacy and safety of Hopea parviflora. By offering an integrative overview of its phytochemical and pharmacological attributes, this review underscores the plant’s potential as a versatile resource for developing new plant-based therapeutic agents.